REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Running, not enrolling · Phase 3
Conditions studied: Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
In brief
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with locally advanced or metastatic NSCLC with EGFR ex20ins mutations.
Key facts
- Study ID
- NCT05973773
- Run by
- Taiho Oncology, Inc.
- People needed
- 285
- Starts
- 2023-12-18
- Expected to finish
- 2027-05-27
- Last updated by the study team
- 2026-07-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Horizon Ridge Henderson — Henderson, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Southeast Henderson - Stephanie — Henderson, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Summerlin Medical Center II — Las Vegas, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Southwest — Las Vegas, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Central Valley - Twain — Las Vegas, Nevada, United States
- Comprehensive Cancer Centers of Nevada - Northwest — Las Vegas, Nevada, United States
- Gabrail Cancer and Research Center — Canton, Ohio, United States
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg — Leuven, Flemish Brabant, Belgium
- Algemeen Ziekenhuis Maria Middelares — Ghent, Oost-Vlaaderen, Belgium
- Algemeen Ziekenhuis Delta - Campus Menen — Menen, West Flanders, Belgium
- Algemeen Ziekenhuis Delta - Campus Rumbeke — Rosières, West-Vlaanderen, Belgium
- Centro Regional Integrado de Oncologia — Fortaleza, Ceará, Brazil
- Hospital Mãe de Deus - Centro Integrado de Oncologia — Porto Alegre, Rio Grande do Sul, Brazil
- Hospital São Lucas da PUCRS — Porto Alegre, Rio Grande do Sul, Brazil
- Clínica Neoplasias Litoral — Itajaí, Santa Catatina, Brazil
- Hospital Amaral Carvalho — Jaú, São Paulo, Brazil
- Multi-profile Hospital for Active Treatment Uni Hospital — Panagyurishte, Pazardzhik, Bulgaria
- BC Cancer Vancouver — Vancouver, British Columbia, Canada
- William Osler Health System - Brampton Civic Hospital — Brampton, Ontario, Canada
- Princess Margaret Cancer Centre — Toronto, Ontario, Canada
- CentroEstudiosClinicosSAGA — Santiago, Region de Santiago, Chile
- Hospital Clínico Universidad de Chile — Independencia, Santiago Metropolitan, Chile
- University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna-ISUL — Sofia, Sofia, Bulgaria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.